Moderna is set to ask federal regulators in June for approval to use its vaccine with adolescents, and pediatric infectious disease experts at Emory University are excited about recent news of the vaccine's effectiveness in kids between 12 and 17 years old. "This adds a second tool to the toolbox," said Emory